The UK Government signs influenza pandemic contract with GlaxoSmithKline for Relenza®

Correspondence: Nirmatrelvir–ritonavir suppresses viral load but may attenuate spike antibody response

This correspondence article discusses findings from the PANORAMIC trial published in The Lancet Microbe, showing that nirmatrelvir–ritonavir

BMJ study warns UK-US pharma trade deal could cause 229,000 excess NHS deaths

Research published in the British Medical Journal (BMJ) warns that a UK-US pharmaceutical trade deal signed in December could cause an estim

Sanofi to Stop Disparaging Rival Flu Vaccine to Stave Off EU Antitrust Fine

UK Health Security Agency: Over 25% Chance of New Pandemic Within 5 Years

The UK Health Security Agency (UKHSA) has published its first Health Security Risk Assessment (HSRA), warning that there is more than a 25%

Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health

This article argues that the UK-US pharmaceuticals trade deal, announced on 1 December 2025, will harm public health by diverting billions o

Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health

This article argues that the UK-US pharmaceuticals trade deal, announced on 1 December 2025, will harm public health by diverting billions o

Analysis: UK-US trade deal could force NHS to divert £45bn, causing 229,000 excess deaths in England

Analysis suggests the UK-US trade deal agreed in December will force the NHS to divert £45bn from essential services to pay for more expensi